Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.5.4) appears in the study record history, replacing the prior revision (v3.5.3). This indicates updates have been applied to the study record since the last submission.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe record history now shows a new revision entry (v3.5.3) replacing the previous revision (v3.5.2), updating the study record's version history.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3 from the record.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision: v3.4.2 was added to the record history. Outdated notices including a funding-status warning and Revision: v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.